Co-mutations of CTNNB1 and PTEN drive aggressive tumor progression in endometrial cancer
{{output}}
Endometrioid endometrial cancer (EEC) is the most prevalent gynecological malignancy. While early-stage EEC typically carries a favorable prognosis, late-stage EEC shows significantly poorer outcomes, with a five-year survival rate of only 17-19%. Co-occurring... ...
